APA-viite

Srkalovic, G., Hussein, M. A., Hoering, A., Zonder, J. A., Popplewell, L. L., Trivedi, H., . . . Barlogie, B. (2014). A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434. Cancer Med.

Chicago-tyylinen lähdeviittaus

Srkalovic, Gordan, et al. "A Phase II Trial of BAY 43-9006 (sorafenib) (NSC-724772) in Patients With Relapsing and Resistant Multiple Myeloma: SWOG S0434." Cancer Med 2014.

MLA-viite

Srkalovic, Gordan, et al. "A Phase II Trial of BAY 43-9006 (sorafenib) (NSC-724772) in Patients With Relapsing and Resistant Multiple Myeloma: SWOG S0434." Cancer Med 2014.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.